Literature DB >> 28138879

Development of Novel Warfarin-Silica Composite for Controlled Drug Release.

Elena V Parfenyuk1, Ekaterina S Dolinina2.   

Abstract

PURPOSE: The work is devoted to synthesis and study of warfarin composites with unmodified, methyl and phenyl modified silica in order to develop controlled release formulation of the anticoagulant.
METHODS: The composites were prepared by two routes, adsorption and sol-gel, and characterized with FTIR spectroscopy, dynamic light scattering and DSC methods. The drug release behavior from the composites in media with pH 1.6, 6.8 and 7.4 was analyzed in vitro. The release kinetics of the warfarin - silica composites prepared by the two routes was compared among each other and with analogous silica composites with water soluble drug molsidomine.
RESULTS: The comparative analysis showed that in general the kinetic regularities and mechanisms of release for both drugs are similar and determined by nonuniform distribution of the drugs over the silica matrixes and stability of the matrixes in the studied media for the adsorbed composites and uniformly distributed drug and more brittle structure for the sol-gel composites.
CONCLUSIONS: The sol-gel composite of warfarin - phenyl modified silica is perspective for further development of novel warfarin formulation with controlled release because it releases warfarin according to zero-order kinetic law with approximately equal rate in the media imitating different segments of gastrointestinal tract.

Entities:  

Keywords:  adsorption; controlled release; drug-silica composites; release kinetics; sol-gel; warfarin

Mesh:

Substances:

Year:  2017        PMID: 28138879     DOI: 10.1007/s11095-017-2111-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  Restricted diffusion and release of aroma molecules from sol-gel-made porous silica particles.

Authors:  Susanne R Veith; Eric Hughes; Sotiris E Pratsinis
Journal:  J Control Release       Date:  2004-09-30       Impact factor: 9.776

2.  Preformulation study of the inclusion complex warfarin-beta-cyclodextrin.

Authors:  G Zingone; F Rubessa
Journal:  Int J Pharm       Date:  2004-12-28       Impact factor: 5.875

3.  Determination of the physical state of drug molecules in mesoporous silicon with different surface chemistries.

Authors:  Joakim Riikonen; Ermei Mäkilä; Jarno Salonen; Vesa-Pekka Lehto
Journal:  Langmuir       Date:  2009-06-02       Impact factor: 3.882

4.  Hybrid organic-inorganic silica gel carriers with controlled drug-delivery properties.

Authors:  Laura Contessotto; Elena Ghedini; Francesco Pinna; Michela Signoretto; Giuseppina Cerrato; Valentina Crocellà
Journal:  Chemistry       Date:  2009-11-09       Impact factor: 5.236

5.  1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987.

Authors:  Nicholas A Peppas
Journal:  J Control Release       Date:  2014-09-28       Impact factor: 9.776

6.  Design of silica carrier for controlled release of molsidomine: effect of preparation methods of silica matrixes and their composites with molsidomine on the drug release kinetics in vitro.

Authors:  Elena V Parfenyuk; Ekaterina S Dolinina
Journal:  Eur J Pharm Biopharm       Date:  2014-09-28       Impact factor: 5.571

7.  Development of Novel Delivery System for Cardiovascular Drug Molsidomine: Influence of Synthesis Method and Conditions on Molsidomine Release From Its Composites With Hydrophilic Silica In Vitro.

Authors:  Ekaterina S Dolinina; Elena V Parfenyuk
Journal:  J Pharm Sci       Date:  2016-06       Impact factor: 3.534

8.  Silica xerogel carrier material for controlled release of toremifene citrate.

Authors:  M Ahola; P Kortesuo; I Kangasniemi; J Kiesvaara; A Yli-Urpo
Journal:  Int J Pharm       Date:  2000-02-15       Impact factor: 5.875

9.  Spectroscopic evidence for the presence of the cyclic hemiketal form of warfarin in aqueous solution: consequences for bioavailability.

Authors:  Annika M Rosengren; Björn C G Karlsson
Journal:  Biochem Biophys Res Commun       Date:  2011-03-05       Impact factor: 3.575

10.  Drug entrapment in silica microspheres through a single step sol-gel process and in vitro release behavior.

Authors:  Elvan Yilmaz; Murat Bengisu
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2006-04       Impact factor: 3.368

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.